Turning microbiome research into a force for health
A diverse group of researchers is working to turn new discoveries about the trillions of microbes in the body into treatments for a range of diseases.
A diverse group of researchers is working to turn new discoveries about the trillions of microbes in the body into treatments for a range of diseases.
Unbiased, high-throughput analysis pipeline improves utility of “minibrains” for understanding development and diseases such as Zika infection.
Applications and challenges of sensing technology have been accelerated by Covid-19.
As cases increased worldwide this spring, mechanical engineers developed solutions to help slow and stop the spread of the coronavirus.
MISTI Global Seed Funds are open for proposals after Covid pivot.
Will focus on responding to disasters and humanitarian crises, defending against biothreats, addressing climate change, and improving human health and performance.
Machine learning model predicts probability that a particular urinary tract infection can be treated by specific antibiotics.
Mathematical analysis suggests that preventing large gatherings could significantly reduce Covid-19 infection rates.
United under the Sustainability Incubator Fund, researchers strategize sustainable sourcing solution for crises at the local and global level.
MIT conference illustrates technologies developed in response to the pandemic and new opportunities for AI solutions for clinical management.
Award cites major contributions to statistical analysis of brain activity and advancing the neuroscience of anesthesia.
By accounting for sweat physiology, method can make better use of electrodermal activity for tracking subconscious changes in physical or emotional state.
Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells.
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program.